Filtern
Erscheinungsjahr
Dokumenttyp
- Zeitschriftenartikel (121)
- Vortrag (49)
- Posterpräsentation (17)
- Beitrag zu einem Tagungsband (3)
- Buchkapitel (2)
- Sonstiges (1)
Schlagworte
- Immunoassay (50)
- ELISA (37)
- Biosensoren (15)
- Antikörper (14)
- Carbamazepine (12)
- Abwasser (11)
- Antibody (10)
- Biomarkers (9)
- Biosensor (9)
- Koffein (9)
Organisationseinheit der BAM
- 1 Analytische Chemie; Referenzmaterialien (75)
- 1.8 Umweltanalytik (75)
- 6 Materialchemie (8)
- 1.9 Chemische und optische Sensorik (7)
- 6.1 Oberflächen- und Dünnschichtanalyse (5)
- P Präsident (5)
- P.0 Präsident und andere (5)
- 1.5 Proteinanalytik (3)
- 6.3 Strukturanalytik (3)
- 1.0 Abteilungsleitung und andere (2)
Paper des Monats
- ja (1)
Eingeladener Vortrag
- nein (49)
The non-steroidal anti-inflammatory drug (NSAID) diclofenac (DCF) is an important environmental contaminant occurring in surface waters all over the world, because, after excretion, it is not adequately removed from wastewater in sewage treatment plants. To be able to monitor this pollutant, highly efficient analytical methods are needed, including immunoassays. In a medical research project, monoclonal antibodies against diclofenac and its metabolites had been produced. Based on this monoclonal anti-DCF antibody, a new indirect competitive enzyme-linked immunosorbent assay (ELISA) was developed and applied for environmental samples. The introduction of a spacer between diclofenac and the carrier protein in the coating conjugate led to higher sensitivity. With a test midpoint of 3 mg L−1 and a measurement range of 1–30 mg L−1, the system is not sensitive enough for direct analysis of surface water. However, this assay is quite robust against matrix influences and can be used for wastewater. Without adjustment of the calibration, organic solvents up to 5%, natural organic matter (NOM) up to 10 mg L−1, humic acids up to 2.5 mg L−1, and salt concentrations up to 6 g L−1 NaCl and 75 mg L−1 CaCl2 are tolerated. The antibody is also stable in a pH range from 3 to 12. Cross-reactivity (CR) of 1% or less was determined for the metabolites 40-hydroxydiclofenac (40-OH-DCF), 5-hydroxydiclofenac (5-OH-DCF), DCF lactam, and other NSAIDs. Relevant cross-reactivity occurred only with an amide derivative of DCF, 6-aminohexanoic acid (DCF-Ahx), aceclofenac (ACF) and DCF methyl ester (DCF-Me) with 150%, 61% and 44%, respectively. These substances, however, have not been found in samples. Only DCF-acyl glucuronide with a cross-reactivity of 57% is of some relevance. For the first time, photodegradation products were tested for cross-reactivity. With the ELISA based on this antibody, water samples were analysed. In sewage treatment plant effluents, concentrations in the range of 1.9–5.2 mg L−1 were determined directly, with recoveries compared to HPLC-MS/MS averaging 136%.
Concentrations in lakes ranged from 3 to 4.4 ng L−1 and were, after pre-concentration, determined with an average recovery of 100%
Alternative Tools (AT) such as on-site test kits, on-site portable devices and continuous measuring devices, are useful to improve water quality assessment under EU directives, and water treatment processes, thus contributing to improving water management, as well as get insights on the dynamic of pollutants within water bodies. Although these tools have clear advantages (e.g. fast response allowing for real-time monitoring, ease-of-use, lower cost), they are perceived as less reliable than conventional analytical methods. Their alternative nature, innovative status, and non-standard operation mode require specific validation strategies that differ significantly from those of conventional analytical methods. Nevertheless, the validation of ATs, especially on-site test kits, portable devices and continuous measuring devices for water quality monitoring is crucial to support their acceptance, promote their use and make their application sustainable. In this paper, a validation procedure in 4 steps is proposed: (1) Comprehensive description of the AT; (2) Assessment of intrinsic metrological performance and operational factors within a single laboratory; (3) Assessment of inter-laboratory performances through an inter-laboratory comparison and, (4) Demonstration of the equivalence of results between the AT and a reference method. This paper discusses each step of the validation procedure, and examples to illustrate critical issues are provided.
The presence of endocrine-disrupting compounds (EDCs) in water poses a significant threat to human and animal health, as recognized by regulatory agencies throughout the world. The Yeast Estrogen Screen (YES) assay is an excellent method to evaluate the presence of these compounds in water due to its simplicity and capacity to assess the bioaccessible forms/fractions of these compounds. In the presence of a compound with estrogenic activity, Saccharomyces cerevisiae cells, containing a lacZ reporter gene encoding the enzyme β-galactosidase, are induced, the enzyme is synthesised, and released to the extracellular medium. In this work, a YES-based approach encompassing the use of a lacZ reporter gene modified strain of S. cerevisiae, microcarriers as solid support, and a fluorescent substrate, fluorescein di-β-D-galactopyranoside, is proposed, allowing for the assessment of EDCs’ presence after only 2 h of incubation. The proposed method provided an EC50 of 0.17 ± 0.03 nM and an LLOQ of 0.03 nM, expressed as 17β-estradiol. The assessment of different EDCs provided EC50 values between 0.16 and 1.2 × 103 nM. After application to wastewaters, similar results were obtained for EDCs screening, much faster, compared to the conventional 45 h spectrophotometric procedure using a commercial kit, showing potential for onsite high-throughput screening of environmental contamination.
Analytische Methoden für die Quantifizierung von Mikroschadstoffen (Synonym für Spurenstoffe) und Pathogenen im Wasser sind eine Grundvoraussetzung für die Umsetzung des Ziels Nr. 6 für Nachhaltige Entwicklung der UN, weltweit sauberes Wasser zur Verfügung zu stellen. Dafür sind schnelle, einfach zu bedienende und kostengünstige Überwachungssysteme notwendig. Antikörperbasierte Biosensoren haben das Potential, z.B. die Eliminationsleistung bezüglich kleiner organischer Moleküle durch die vierte Reinigungsstufe von Kläranlagen vor Ort zu überwachen. Darüber hinaus kommt modernen bioanalytischen Verfahren bei der Quantifizierung von Pathogenen eine immer wichtigere Rolle zu. Neben einer Bestandsaufnahme zu diesen Themen ist es das Ziel dieses Beitrags, die Anwendungsbarrieren von Biosensoren für die Wasseranalytik von Mikroschadstoffen abbauen zu helfen und die Vorzüge moderner bioanalytischer Methoden für die Quantifizierung von Pathogenen aufzuzeigen.
Der Vortrag beschreibt den Stand der Arbeiten an der BAM, Fachbereich Umweltanalytik zur Entwicklung von Sensoren für die Wasseranalytik. Er stellt die bisherigen Arbeiten da, die ausgehend von ELISAs, zunehmend portable Plattformen wie FPIA und LFIA umfassen. Beas-based Formate werden von mikrotiterplatten-basierten Techniken auf mikrofluidische Lab-on-Chip-Systeme übertragen, die bei geeigneter Miniaturisierung und Automatisierung als Sensorsysteme angesehen werden können. Der Vortrag endet mit einem Blick auf ein laufendes Monitoring-Projekt von anthropogenen Markern in Abwasser und charakterisiert die Treiber, die die Entwicklung von Sensoren für die Wasseranalytik in den letzten Jahren vorantreiben.
Der One-Health-Ansatz hat die Gesundheit von Mensch, Tier und Umwelt im Fokus. Dazu ist eine interdisziplinäre Zusammenarbeit von Akteuren aus Human- und Veterinärmedizin sowie den Umweltwissenschaften notwendig. Ein Ineinandergreifen von methodischen Ansätzen und der Analytik wird angestrebt.
Im Zuge der anstehenden Novellierung (2924) der EU-Kommunalabwasserrichtlinie (91/271/EWG) wird die Umsetzung eines One-Health-Ansatzes bereits adressiert. Dazu gehört zum einen der Ausbau und die Prozessüberwachung einer vierten Reinigungsstufe in Klärwerken. Zum anderen ist europaweit die Infrastruktur einer Abwassersurveillance zur Überwachung von Krankheitserregern zu gewährleisten. Dies wird aktuell in Deutschland mit dem Projekt AMELAG ("Abwassermonitoring zur epidemiologischen Lagebewertung") mit zwei Probennahmen pro Woche auf ca. 170 Kläranlagen umgesetzt.
The environmental fate of the frequently used broad-spectrum β-lactam antibiotic amoxicillin (AMX) is of high concern regarding the potential evolution of antimicrobial resistance (AMR). Moreover, it is known that AMX is prone to hydrolysis, yielding a variety of hydrolysis products (HPs) with yet unknown effects. Studies to identify those HPs and investigate their formation mechanisms have been reported but a long-term study on their stability in real water samples was missing. In this regard, we investigated the hydrolysis of AMX at two concentration levels in four distinct water types under three different storage conditions over two months. Concentrations of AMX and four relevant HPs were monitored by an LC-MS/MS method revealing pronounced differences in the hydrolysis rate of AMX in tap water and mineral water on the one hand (fast) and surface water on the other(slow). In this context, the occurrence, relative intensities, and stability of certain HPs are more dependent on the water type than on the storage condition. As clarified by ICP-MS, the main difference between the water types was the content of the metals copper and zinc which are supposed to catalyze AMX hydrolysis demonstrating an effective method to degrade AMX at ambient conditions.
A certain group of mycotoxins, the ergot alkaloids, has caused countless deaths throughout human history. They are found in rye and other cereals and ingesting contaminated foods can cause serious health problems. To identify contaminated food exceeding the legal limits for ergot alkaloids, a portable and cost-effective test system is of great interest to the food industry. Rapid analysis can be achieved by screening for a marker compound, for which we chose ergometrine. We developed a magnetic bead-based immunoassay for ergometrine with amperometric detection in a flow injection system using a handheld potentiostat and a smartphone. With this assay a limit of detection of 3 nM (1 μg/L) was achieved. In spiked rye flour, ergometrine levels from 25 to 250 μg/kg could be quantified. All results could be verified by optical detection. The developed assay offers great promise to meet the demand for on-site ergometrine detection in the food industry.
Functionalized Ti3C2Tx nanosheets based biosensor for point-of-care detection of SARS-CoV‑2 antigen
(2023)
MXenes are considered a promising class of two-dimensional materials with extraordinary physical and electrochemical properties. Distinguished features like high specific surface area and outstanding electrical conductivity make them suitable for electrochemical biosensing applications. Here, we report the development of a biosensor involving the functionalized MXene−titanium carbide nanosheets (Ti3C2Tx-NS) and monoclonal antibodies against the SARS-CoV-2 nucleocapsid protein (anti-SARS-CoV-2 mAb) to design a point-of-care device for detection of the SARS-CoV-2 nucleocapsid protein (SARS-CoV-2 NP) antigen. Few-layered titanium carbide nanosheets (denoted as FL-Ti3C2Tx-NS) have been synthesized using a single-step etching and delamination method and characterized using optical and electron microscopy techniques revealing the suitability for immunosensing applications. Binding studies revealed the excellent affinity between the biosensor and the SARS-CoV-2 NP. Electrochemical detection of SARS-CoV-2 NP is performed using differential pulse voltammetry and read by a smartphone-based user interface. The proposed FL-Ti3C2Tx-NS based biosensor offers the detection of SARS-CoV-2 NP with a limit of detection of 0.91 nM in a wide detection range in spiked saliva samples. Additionally, there is no cross-reactivity in the presence of potential interferants like SARS-CoV-2 spike glycoprotein and bovine serum albumin. These findings demonstrate the potential of MXenes in developing a rapid and reliable tool for SARS-CoV-2 NP detection. While we report the biosensing of SARS-CoV-2 NP, our system also paves the way for the detection of other SARS-CoV-2 antigens like spike protein or other biomolecules based on antigen−antibody interactions.
Immunoassays, based on the recognition and capture of analytes by highly selective antibodies, are now used extensively in all areas of diagnostics, but the challenge is to further integrate them into online sensors. To improve the transition from laboratory immunoassays to immunosensors, we have developed a complete flow system, based on a microfluidic core flow cell to enable automated detection of one of the most commonly used immunoassay substrates, TMB, by chronoamperometry. The architecture and fluidic optimisation of the system showed that a specially designed 3D flow cell allows higher flow rates (500 μL min−1) than a standard enlarged microfluidic channel (50 μL min−1) resulting in a significantly shorter detection time of 30 seconds per sample and making the system more robust against interferences due to bubble formation in the chip. The electrochemical measurements showed an improved signal-to-noise ratio (SNR) and thus higher sensitivity for a model immunoassay for diclofenac (SNR = 59), compared to the analytical performance of a conventional laboratory microplate-based assay with optical detection (SNR = 19). In general, this system facilitates the conversion of any conventional immunoassay into an immunosensor with automatic and continuous detection.